Sfoglia per AUTORE
AERTS S
Collezione AO Ordine Mauriziano
Items : 2
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab. in Journal of clinical medicine / J Clin Med. 2021 Mar 2;10(5):1005. doi: 10.3390/jcm10051005.
2021
AO Ordine Mauriziano
AO Ordine Mauriziano
Di Maio M; Chiari R; Ficorella C; Cortellini A; Aerts S; Caglio A; Nicolardi L; Rinaldi S; Paoloni F; Ranallo N; Lupi A; Mentrasti G; Agostinelli V; Cognigni V; Pecci F; Cantini L; Lenci E; Dingemans AC; Aerts JGJV; Berardi R;
FP12.06 GRIm-Score Variations Predict Outcome in Metastatic NSCLC Patients Treated with First-Line Pembrolizumab in Journal of Thoracic Oncology
2021
AO Ordine Mauriziano
AO Ordine Mauriziano
Caglio A; Aerts S; Berardi R; Dingemans A; Nicolardi L; Lupi A; Paoloni F; Cortellini A; Ficorella C; Chiari R; Di Maio M; Aerts J; Agostinelli V; Mentrasti G; Ranallo N; Lenci E; Cantini L; Rinaldi S; Pecci F; Cognigni V;